Previous studies [9,10,11,12,13,14] have shown that the aggregation or sequestration of free iron may occur due to the abnormal expression of free iron carriers, such as divalent metal transporter 1 (DMT1) and ferroportin 1 (FPN1), which play a central role in PD pathogenesis. This evidence concerns the gene SLC11A2 and Parkinson disease.